A Study to Evaluate a Pressure Monitoring Device to Improve Safety and Patient Comfort During Nerve Block for Upper Limb Surgery

Evaluation of the PNB Guard Pressure Monitoring Device on Hemodynamic, and Subjective Outcomes During Supraclavicular Brachial Plexus Block: A Randomised controlled study. - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/105316

Enrollment

Registered

2026-03-03

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M966- Fracture of bone following insertion of orthopedic implant, joint prosthesis, or bone plate

Interventions

Intervention1: PNB Guard (same dose of drug): The PNB Guard device offers realtime pressure feedback during local anesthetic injection, alerting the operator to abnormal resistance that may warrant re

Eligibility

Inclusion criteria

Inclusion criteria: ASA Physical Status I and III Scheduled for elective upper limb surgery Willing to give informed consent

Exclusion criteria

Exclusion criteria: Allergy to Local Anaesthetic Coagulopathy and bleeding disorders Local infection at the site Severepulmonary or neurological conditions Patients unable to cooperate or communicate pain score

Design outcomes

Primary

Measure	Time frame
This study could help determine whether incorporating pressure monitoring with PNB Guard provides added safety and efficiency benefits compared to traditional techniques. If successful, this may support the wider adoption of pressure-monitoring technology in regional anesthesia practice.Timepoint: 15 mins after the procedure	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactSushmita Chundury

Datta meghe medical college

drsushmitachundury@gmail.com9989024548

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026